Yes, progressive cytopenias and macrocytosis over seven years are characteristic features of myelodysplastic syndrome
The clinical course you describe—developing thrombocytopenia, leukopenia (specifically neutropenia), and progressive macrocytosis from MCV 93 to 101 fL over seven years—is entirely consistent with the natural history of MDS, particularly lower-risk disease. This represents the typical pattern of ineffective hematopoiesis that defines these disorders 1, 2.
Why This Progression is Expected in MDS
MDS is fundamentally characterized by progressive bone marrow failure manifesting as peripheral blood cytopenias 3. The major clinical morbidities are specifically cytopenia-associated complications 1. Your progression demonstrates:
Progressive cytopenias: Thrombocytopenia (platelets <100 × 10⁹/L) occurs in approximately 30% of lower-risk MDS patients, while neutropenia (<1.8 × 10⁹/L) is seen in about 7% 2. The development of multiple cytopenias over time reflects the clonal expansion and progressive marrow dysfunction.
Macrocytosis evolution: Your MCV progression from 93 to 101 fL over seven years is classic. Macrocytosis is a hallmark feature of MDS, though interestingly, patients with MCV ≤100 fL actually have worse prognosis in lower blast count disease 4. The gradual increase reflects worsening ineffective erythropoiesis.
Timeline Considerations
The seven-year timeframe is entirely appropriate for lower-risk MDS. According to the IPSS-R prognostic system, patients with very low-risk disease have a median overall survival of 8.8 years, while low-risk patients have 5.3 years 2. Your indolent progression over seven years suggests you likely fall into the lower-risk categories, where the disease evolves slowly rather than rapidly transforming to acute leukemia.
Mechanisms Behind Your Progression
The cytopenias develop through multiple mechanisms 5:
- Differentiation block of progenitor cells
- Increased apoptosis of megakaryocytes and their precursors (explaining thrombocytopenia)
- Dysregulated thrombopoietin signaling
- Ineffective hematopoiesis across all lineages
The macrocytosis specifically reflects impaired DNA synthesis and dysplastic erythropoiesis characteristic of MDS 3.
Important Caveats
You must ensure other causes of macrocytosis and cytopenias have been excluded, particularly vitamin B12 and folate deficiency, which can mimic MDS 6, 7. This is crucial because megaloblastic anemia from nutritional deficiencies is treatable, while MDS is not curable without stem cell transplantation. The differential diagnosis can be challenging even for pathologists, who can only make a definitive distinction in about 55% of cases based on bone marrow histology alone 7.
The gradual nature of your progression (seven years) actually supports MDS over acute processes, but regular monitoring with bone marrow examinations and cytogenetic/molecular studies is essential to track disease evolution and detect any transformation toward higher-risk disease or acute leukemia 1, 2.